dysiherbaine

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedysiherbaine
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonistsGlutamate receptor ionotropic kainate antagonists
TargetsGlutamate receptor ionotropic kainateGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsPsychotic DisordersCognition DisordersDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Suntory Biomedical Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Suntory Biomedical Research Co Ltd
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersCognition DisordersDepression

Other Information

ATC CodeN/A
Related LinksN/A